This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Conflicted on These NA Names: LATAM Airlines Group SA Sponsored ADR (LTM), vTv Therapeutics (VTVT) and Once Upon a Farm, PBC (OFRM)

Tipranks - Tipranks - Tue Aug 11, 3:04AM CDT

Analysts have been eager to weigh in on the NA sector with new ratings on LATAM Airlines Group SA Sponsored ADR (LTM), vTv Therapeutics (VTVT) and Once Upon a Farm, PBC (OFRM).

Claim 55% Off TipRanks

LATAM Airlines Group SA Sponsored ADR (LTM)

Morgan Stanley analyst Jens Spiess maintained a Buy rating on LATAM Airlines Group SA Sponsored ADR today. The company’s shares closed last Friday at $56.72.

According to TipRanks.com, Spiess is a 4-star analyst with an average return of 13.7% and a 71.9% success rate. Spiess covers the Industrial Goods sector, focusing on stocks such as Grupo Aeroportuario del Pacifico, Grupo Aeroportuario del Sureste, and Grupo Aeroportuario Del Centro. ;'>

Currently, the analyst consensus on LATAM Airlines Group SA Sponsored ADR is a Strong Buy with an average price target of $70.87, representing a 23.2% upside. In a report issued on August 5, TipRanks – OpenAI also upgraded the stock to Buy with a $61.00 price target.

See today’s best-performing stocks on TipRanks >>

vTv Therapeutics (VTVT)

In a report issued on August 7, Ritu Baral from TD Cowen maintained a Buy rating on vTv Therapeutics, with a price target of $67.00. The company’s shares closed last Friday at $35.37.

According to TipRanks.com, Baral is a top 100 analyst with an average return of 48.0% and a 58.8% success rate. Baral covers the Healthcare sector, focusing on stocks such as Sagimet Biosciences, Inc. Class A, Praxis Precision Medicines, and Milestone Pharmaceuticals. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for vTv Therapeutics with a $57.67 average price target, representing a 66.6% upside. In a report issued on July 31, Roth MKM also maintained a Buy rating on the stock with a $58.00 price target.

Once Upon a Farm, PBC (OFRM)

In a report released today, Andrew Lazar from Barclays maintained a Hold rating on Once Upon a Farm, PBC, with a price target of $19.00. The company’s shares closed last Friday at $17.93.

According to TipRanks.com, Lazar is a 3-star analyst with an average return of 1.1% and a 52.1% success rate. Lazar covers the Consumer Goods sector, focusing on stocks such as Mondelez International, Lamb Weston Holdings, and McCormick & Company. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Once Upon a Farm, PBC with a $23.60 average price target, which is a 42.0% upside from current levels. In a report issued on August 7, TD Cowen also maintained a Hold rating on the stock with a $20.00 price target.

Read More on LTM:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).